We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

1,177 hedge funds and large institutions have $75.1B invested in Regeneron Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 401 increasing their positions, 446 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 111 | Existing positions closed: 87

13% more capital invested

Capital invested by funds: $66.2B → $75.1B (+$8.91B)

4% more funds holding in top 10

Funds holding in top 10: 28 → 29 (+1)

1% more funds holding

Funds holding: 1,165 → 1,177 (+12)

0.39% less ownership

Funds ownership: 85.84% → 85.45% (-0.39%)

10% less repeat investments, than reductions

Existing positions increased: 401 | Existing positions reduced: 446

11% less call options, than puts

Call options by funds: $1.43B | Put options by funds: $1.61B

Holders
1,177
Holders Change
+12
Holders Change %
+1.03%
% of All Funds
18.68%
Holding in Top 10
29
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.57%
% of All Funds
0.46%
New
111
Increased
401
Reduced
446
Closed
87
Calls
$1.43B
Puts
$1.61B
Net Calls
-$183M
Net Calls Change
+$45.7M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$664M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$526M
3
WP
Woodline Partners
California
+$69.9M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$64.9M
5
ZIG
Zurich Insurance Group
Switzerland
+$62.3M

Top Sellers

1
EWA
EP Wealth Advisors
California
-$446M
2
Capital World Investors
Capital World Investors
California
-$348M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$248M
4
BlackRock
BlackRock
New York
-$166M
5
Invesco
Invesco
Georgia
-$130M
Name Holding Trade Value Shares
Change 		Change in
Stake
RWPA
1151
Richard W. Paul & Associates
Michigan
$3.29K -$2.36K -3 -43%
CB
1152
CNB Bank
Pennsylvania
$3.29K – – –
FRA
1153
Front Row Advisors
California
$3.29K – – –
HFM
1154
Hartford Financial Management
Connecticut
$3.29K +$786 +1 +33%
PCTC
1155
Perkins Coie Trust Company
Washington
$3.29K +$3.14K +4 New
ECM
1156
Everence Capital Management
Indiana
$3.02K – – –
TFA
1157
Transamerica Financial Advisors
Florida
$3K -$786 -1 -25%
FGAM
1158
Financial Gravity Asset Management
Texas
$2.68K -$564K -717 -100%
AP
1159
Arlington Partners
Alabama
$2.47K – – –
AT
1160
Arlington Trust
Alabama
$2.47K +$2.36K +3 New
IHWM
1161
Iron Horse Wealth Management
Iowa
$2.47K +$2.36K +3 New
PI
1162
PEAK6 Investments
Illinois
$2.29K +$786 +1 +50%
KFP
1163
KB Financial Partners
New Jersey
$2K – – –
BONH
1164
Bank of New Hampshire
New Hampshire
$1.65K – – –
CTWM
1165
Cherry Tree Wealth Management
Minnesota
$1.65K – – –
HWP
1166
Highline Wealth Partners
California
$1.65K – – –
LIM
1167
Longfellow Investment Management
Massachusetts
$1.65K – – –
NSIM
1168
North Star Investment Management
Illinois
$1.65K – – –
TWD
1169
True Wealth Design
Ohio
$1.65K – – –
WPA
1170
West Paces Advisors
Georgia
$1.65K – – –
WA
1171
WestEnd Advisors
North Carolina
$1.65K +$1.57K +2 New
TWP
1172
TFO Wealth Partners
Ohio
$1.44K +$786 +1 +100%
CAM
1173
ClariVest Asset Management
California
$1K +$786 +1 New
IFAM
1174
Institutional & Family Asset Management
Colorado
$823 – – –
WWM
1175
Wolff Wiese Magana
California
$823 – – –
45 46
47
48 49

REGN Hedge Fund Activity: Q3 2023 in Review

1,177 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q3 2023, worth a combined $75.1B — up 13% from $66.2B a quarter earlier.

Buyers outnumbered sellers: 111 funds opened new REGN positions and 87 closed out — a net gain of 24 holders — while 401 added to existing stakes and 446 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $664M. The largest seller was EP Wealth Advisors, cutting an estimated $446M.

  • 1,177 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q3 2023, up from 1,165 in Q2 2023.
  • Funds reported $75.1B of Regeneron Pharmaceuticals stock for Q3 2023, up 13% quarter-over-quarter.
  • 111 funds opened new Regeneron Pharmaceuticals positions in Q3 2023 and 87 closed out, a net change of +24 holders.
  • The largest Regeneron Pharmaceuticals buyer in Q3 2023 was JP Morgan Chase, an estimated $664M added.
  • The largest Regeneron Pharmaceuticals seller in Q3 2023 was EP Wealth Advisors, an estimated $446M sold.

Based on aggregated 13F filings for Q3 2023.